Trial
NCT04388709
Interferon Lambda Therapy for COVID-19
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Eiger BioPharmaceuticals
Condition
SARS-CoV-2
Intervention
Peginterferon Lambda-1A
Why stopped
Due to the number of competing trials at their site, the study team has closed enrollment and withdrawn this trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-26